Literature DB >> 25617203

Incidence and severity of childhood pneumonia in the first year of life in a South African birth cohort: the Drakenstein Child Health Study.

David M le Roux1, Landon Myer2, Mark P Nicol3, Heather J Zar4.   

Abstract

BACKGROUND: Childhood pneumonia causes substantial mortality and morbidity. Accurate measurements of pneumonia incidence are scarce in low-income and middle-income countries, particularly after implementation of pneumococcal conjugate vaccine. We aimed to assess the incidence, severity, and risk factors for pneumonia in the first year of life in children enrolled in a South African birth cohort.
METHODS: This birth cohort study is being done at two sites in Paarl, a periurban area of South Africa. We enrolled pregnant women (>18 years) and followed up mother-infant pairs to 1 year of age. We obtained data for risk factors and respiratory symptoms. Children received 13-valent pneumococcal conjugate vaccine according to national immunisation schedules. We established pneumonia surveillance systems and documented episodes of ambulatory pneumonia and pneumonia warranting hospital admission. We calculated incidence rate ratios for pneumonia with mixed-effects Poisson regression.
FINDINGS: Between May 29, 2012 and May 31, 2014, we enrolled 697 infants who accrued 513 child-years of follow-up. We recorded 141 pneumonia episodes, with an incidence of 0·27 episodes per child-year (95% CI 0·23-0·32). 32 (23%) pneumonia cases were severe pneumonia, with an incidence of 0·06 episodes per child-year (95% CI 0·04-0·08). Two (1%) of 141 pneumonia episodes led to death from pneumonia. Maternal HIV, maternal smoking, male sex, and malnutrition were associated with an increased incidence of pneumonia.
INTERPRETATION: Pneumonia incidence was high in the first year of life, despite a strong immunisation programme including 13-valent pneumococcal conjugate vaccine. Incidence was associated with pneumonia risk factors that are amenable to interventions. Prevention of childhood pneumonia through public health interventions to address these risk factors should be strengthened. FUNDING: Bill & Melinda Gates Foundation, South African Thoracic Society, Federation of Infectious Diseases Societies of South Africa, and University of Cape Town.
Copyright © 2015 le Roux et al. Open Access article distributed under the terms of CC BY-NC-ND. Published by .. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25617203     DOI: 10.1016/S2214-109X(14)70360-2

Source DB:  PubMed          Journal:  Lancet Glob Health        ISSN: 2214-109X            Impact factor:   26.763


  44 in total

1.  Investment Long Overdue in Primary Studies of HIV-exposed Uninfected Infant Infectious Morbidity.

Authors:  Amy L Slogrove; Kathleen M Powis
Journal:  Pediatr Infect Dis J       Date:  2019-07       Impact factor: 2.129

2.  Pneumonia in HIV-exposed and Infected Children and Association With Malnutrition.

Authors:  Pui-Ying Iroh Tam; Matthew O Wiens; Jerome Kabakyenga; Julius Kiwanuka; Elias Kumbakumba; Peter P Moschovis
Journal:  Pediatr Infect Dis J       Date:  2018-10       Impact factor: 2.129

3.  A Systematic Review and Meta-analysis of Sex Differences in Morbidity and Mortality of Acute Lower Respiratory Tract Infections Among African Children.

Authors:  Adebola E Orimadegun; Adedayo A Adepoju; Landon Myer
Journal:  J Pediatr Rev       Date:  2020-04

4.  Non-diphtheriae Corynebacterium species are associated with decreased risk of pneumococcal colonization during infancy.

Authors:  Matthew S Kelly; Catherine Plunkett; Yahe Yu; Jhoanna N Aquino; Sweta M Patel; Jillian H Hurst; Rebecca R Young; Marek Smieja; Andrew P Steenhoff; Tonya Arscott-Mills; Kristen A Feemster; Sefelani Boiditswe; Tirayaone Leburu; Tiny Mazhani; Mohamed Z Patel; John F Rawls; Jayanth Jawahar; Samir S Shah; Christopher R Polage; Coleen K Cunningham; Patrick C Seed
Journal:  ISME J       Date:  2021-09-11       Impact factor: 10.302

Review 5.  Vaccines to prevent pneumonia in children - a developing country perspective.

Authors:  Jacquie N Oliwa; Ben J Marais
Journal:  Paediatr Respir Rev       Date:  2015-08-19       Impact factor: 2.726

6.  Study protocol of the Edinburgh and Lothian Virus Intervention Study in Kids: a randomised controlled trial of hypertonic saline nose drops in children with upper respiratory tract infections (ELVIS Kids).

Authors:  Sandeep Ramalingam; Catriona Graham; Katherine Oatey; Phillip Rayson; Andrew Stoddart; Aziz Sheikh; Steve Cunningham
Journal:  BMJ Open       Date:  2021-05-05       Impact factor: 2.692

7.  Reply to Anderson and Caniza.

Authors:  Morgan Congdon; Tonya Arscott-Mills; Matthew S Kelly
Journal:  Clin Infect Dis       Date:  2021-11-02       Impact factor: 20.999

8.  Pneumococcal vaccination and childhood pneumonia in South Africa.

Authors:  Kim Mulholland; Cattram Nguyen
Journal:  Thorax       Date:  2015-09-22       Impact factor: 9.139

9.  Stunting is associated with poor outcomes in childhood pneumonia.

Authors:  Peter P Moschovis; Emmanuel O D Addo-Yobo; Salem Banajeh; Noel Chisaka; David C Christiani; Douglas Hayden; Prakash Jeena; William B MacLeod; Greta Mino; Archana Patel; Shamim Qazi; Mathuram Santosham; Donald M Thea; Patricia L Hibberd
Journal:  Trop Med Int Health       Date:  2015-07-15       Impact factor: 2.622

10.  Comparison of a Real-Time Multiplex PCR and Sequetyping Assay for Pneumococcal Serotyping.

Authors:  Felix S Dube; Suzan P van Mens; Lourens Robberts; Nicole Wolter; Paul Nicol; Joseph Mafofo; Samantha Africa; Heather J Zar; Mark P Nicol
Journal:  PLoS One       Date:  2015-09-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.